Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Paola Rogliani, Beatrice Ludovica Ritondo, Bartolomeo Zerillo, Mario Cazzola, Maria Gabriella Matera & Luigino Calzetta. (2020) Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:2, pages 215-223.
Read now
Read now
Zaurbek Aisanov, Sergey Avdeev, Vladimir Arkhipov, Andrey Belevskiy, Alexander Chuchalin, Igor Leshchenko, Svetlana Ovcharenko, Evgeny Shmelev & Marc Miravitlles. (2018) Russian guidelines for the management of COPD: algorithm of pharmacologic treatment. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 183-187.
Read now
Read now
Mario Cazzola, Paola Rogliani, Ermanno Puxeddu, Josuel Ora & Maria Gabriella Matera. (2018) An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?. Expert Review of Respiratory Medicine 12:1, pages 43-54.
Read now
Read now
Articles from other publishers (12)
Stefan-Marian Frent. 2020. Update in Respiratory Diseases. Update in Respiratory Diseases.
Roland Buhl, Dave Singh, Alberto de la Hoz, Wenqiong Xue & Gary T. Ferguson. (2020) Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies. Advances in Therapy 37:8, pages 3485-3499.
Crossref
Crossref
Shigeo Muro, Hajime Yoshisue, Konstantinos Kostikas, Petter Olsson, Pritam Gupta & Jadwiga A. Wedzicha. (2019) Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis. Respirology 25:4, pages 393-400.
Crossref
Crossref
Terrence E. Murphy, Gail J. McAvay, George O. Agogo & Heather G. Allore. (2019) Personalized and typical concurrent risk of limitations in social activity and mobility in older persons with multiple chronic conditions and polypharmacy. Annals of Epidemiology 37, pages 24-30.
Crossref
Crossref
Mònica Aparici, Carla Carcasona, Israel Ramos, José Luís Montero, Raquel Otal, José Luís Ortiz, Julio Cortijo, Carlos Puig, Dolors Vilella, Jorge De Alba, Chris Doe, Amadeu Gavaldà & Montserrat Miralpeix. (2019)
Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M
3
Receptor Antagonist/
β
2
-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety Profile
. Journal of Pharmacology and Experimental Therapeutics 370:1, pages 127-136.
Crossref
Crossref
Miriam Barrecheguren & Marc Miravitlles. (2018) COUNTERPOINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? No. Chest 154:4, pages 749-751.
Crossref
Crossref
Miriam Barrecheguren, Mónica Monteagudo & Marc Miravitlles. (2018) Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care. npj Primary Care Respiratory Medicine 28:1.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators. Chest 154:2, pages 242-248.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD. The American Journal of Medicine 131:6, pages 608-622.
Crossref
Crossref
You Sook Cho. (2018) Precision medicine for the best treatment of chronic obstructive airway disease. Allergy, Asthma & Respiratory Disease 6:3, pages 141.
Crossref
Crossref
Marc Miravitlles, Seungjae BaekVatsal VithlaniRahul Lad. (2018)
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β
2
-Agonist/Long-Acting Muscarinic Antagonists the Same?
. Tuberculosis and Respiratory Diseases 81:3, pages 198.
Crossref
Crossref
David M. G. Halpin. (2018) The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease. Tuberculosis and Respiratory Diseases 81:1, pages 13.
Crossref
Crossref